Immunogenicity, safety and tolerability of meningococcal C conjugate vaccine (MCC) administered concurrently with hexavalent vaccine at 3, 5 and 11 months post-natally to full term (FT) and pre-term (PT) infants

Immunogenicity, safety and tolerability of meningococcal C conjugate vaccine (MCC) administered concurrently with hexavalent vaccine at 3, 5 and 11 months post-natally to full term (FT) and pre-term (PT) infants / S. Esposito, B. Corbellini, R. Droghetti, L. Pugni, E. Tremolati, C. Tagliabue, D. Toneatto, F. Mosca, N. Principi. ((Intervento presentato al 46. convegno Interscience Conference on Antimicrobial Agents and Chemotherapy - ICAAC tenutosi a San Francisco, California nel 2006.